Myeloproliferative neoplasm, unclassifiable
Information
- Disease name
- Myeloproliferative neoplasm, unclassifiable
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03862157 | Active, not recruiting | Phase 1/Phase 2 | Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia | February 27, 2019 | January 31, 2025 |
| NCT03566446 | Completed | Phase 1 | CALR Exon 9 Mutant Peptide Vaccine to Patients With CALR-mutant Myeloproliferative Neoplasms | June 20, 2018 | April 30, 2021 |
| NCT03907774 | Completed | MPN Podcast Pilot Study | June 1, 2019 | November 24, 2019 | |
| NCT05825326 | Completed | Epidemiological and Clinical-pathological Factors of Philadelphia-negative Myeloproliferative Neoplasms in Ecuador | January 1, 2012 | December 31, 2019 | |
| NCT04282187 | Recruiting | Phase 2 | Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms | March 24, 2020 | November 11, 2026 |
| NCT05326919 | Recruiting | The Patient Cohort of the National Center for Precision Medicine in Leukemia | March 28, 2022 | March 2042 |